Effects of continuous exercise on time spent in euglycemia and inflammation under the treatment of insulin degludec in patients with type 1 diabetes – a crossover, randomized trial
Not Applicable
- Conditions
- E10Type 1 diabetes mellitus
- Registration Number
- DRKS00013477
- Lead Sponsor
- Medizinische Universität Graz
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 10
Inclusion Criteria
1)Type 1 Diabetes
2)Aged: 18 – 65 years (both inclusive)
3)A1c 7 - 9% (53 – 75 mmol.mol-1) (both inclusive)
4)Fasting c-peptide < 0.25 nmol.l-1 [21]
5)Intensified insulin therapy
6)Diabetes diagnosed > 12 months
7)BMI 18.5 – 27 kg/m2 (both inclusive)
8)more 150 min per week exercising with moderate intensity or more than 75 min per week exercising with high intensity [22]
Exclusion Criteria
1)Diabetic long-term complications
2)Illness or disease, that confound the study results
3)Interference with insulin action
4)Suspected allergy to trial products
5)Addiction to alcohol
6)Use of drugs
7)Mental incapacity
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Difference in mean time in euglycemia 24 hours after exercise
- Secondary Outcome Measures
Name Time Method